Tolvaptan in Autosomal Dominant Polycystic Kidney Disease (ADPKD): a multicenter real life Italian experience

This real-life study confirms the feasibility, safety, and tolerability of tolvaptan treatment. In order to overcome the challenges of tolvaptan treatment, our experience suggests that a dedicated PKD team may play a key role in implementing strategies focused to reduce drop-out and achieve treatment success.

Authors

Institutions

Publication Details

Journal
Clinical Kidney Journal
Published
2025-05-20
DOI
https://doi.org/10.1093/ckj/sfaf156
Primary Topic
Genetic and Kidney Cyst Diseases
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Tolvaptan in Autosomal Dominant Polycystic Kidney Disease (ADPKD): a multicenter real life Italian experience

Maurizio Garozzo, Matteo Rigato, Raffaella Cravero, Giovanna Capolongo et al.
Clinical Kidney Journal
Genetic and Kidney Cyst Diseases
article

Tolvaptan in Autosomal Dominant Polycystic Kidney Disease (ADPKD): a multicenter real life Italian experience

Maurizio Garozzo, Matteo Rigato, Raffaella Cravero, Giovanna Capolongo, Laura Econimo, Miriam Zacchia, Claudia Izzi, Silvia Lai, Giovanni Giorgio Battaglia, R Cortinovis, Giovambattista Capasso, Francisco Consiglio, Giovanni Stallone, Carlotta Caprara, Daniela Mezzopane, Federica Mescia, Francesco Scolari, Federico Alberici, Fiorella Gastaldon, Adolfo Marco Perrotta, Valeria Cinquina, Rosa Giunta, Dario C. Altieri, Ciro Esposito, Vittoria Esposito, Diego Toso, Letizia Zeni, Marco Guarneri, Carmelita Marcantoni
article en

Abstract

This real-life study confirms the feasibility, safety, and tolerability of tolvaptan treatment. In order to overcome the challenges of tolvaptan treatment, our experience suggests that a dedicated PKD team may play a key role in implementing strategies focused to reduce drop-out and achieve treatment success.

Clinical Kidney JournalVol. 18(11)
University of Foggia (IT), University of Pavia (IT), Policlinico Umberto I (IT), Brescia University (US), University of Catania (IT), Ospedale degli Infermi (IT), ASL Roma (IT), Istituti Clinici Scientifici Maugeri (IT), Surgical Specialties (Canada) (CA), Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia (IT), Biogem (IT), University of Campania "Luigi Vanvitelli" (IT), Regione del Veneto (IT), Instituto de Biomedicina y Genética Molecular de Valladolid (ES), Azienda Ospedaliera Universitaria Policlinico "Paolo Giaccone" di Palermo (IT), Ospedale San Bortolo (IT), Institute of Molecular Biology and Genetics (UA), University of Brescia (IT), Sapienza University of Rome (IT)
No poverty
Openalex Percentile: Top 87%
Genetic and Kidney Cyst Diseases
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.